• Consumer Genomics Market Forecast Shows 24.8% CAGR Surge, Valued at US$ 18.3 Billion by 2034

    The Consumer Genomics Market Size is expected to be worth around US$ 18.3 billion by 2034 from US$ 2.0 billion in 2024, growing at a CAGR of 24.8% during the forecast period 2025 to 2034.

    https://market.us/report/consumer-genomics-market/#overview
    Consumer Genomics Market Forecast Shows 24.8% CAGR Surge, Valued at US$ 18.3 Billion by 2034 The Consumer Genomics Market Size is expected to be worth around US$ 18.3 billion by 2034 from US$ 2.0 billion in 2024, growing at a CAGR of 24.8% during the forecast period 2025 to 2034. https://market.us/report/consumer-genomics-market/#overview
    MARKET.US
    Consumer Genomics Market
    Consumer Genomics Market Size is expected to reach US$ 18.3 billion by 2034 from US$ 2.0 billion in 2024, growing at a CAGR of 24.8%.
    0 Comments 0 Shares 172 Views 0 Reviews
  • Pharmacogenomics Market Role of Clinical Trial Enrichment and Stratification

    The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034. In 2024, North America led the market, achieving over 48.5% share with a revenue of US$ 2.7 Billion.


    Click here for more information: https://market.us/report/pharmacogenomics-market/
    Pharmacogenomics Market Role of Clinical Trial Enrichment and Stratification The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034. In 2024, North America led the market, achieving over 48.5% share with a revenue of US$ 2.7 Billion. Click here for more information: https://market.us/report/pharmacogenomics-market/
    MARKET.US
    Pharmacogenomics Market
    The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034.
    0 Comments 0 Shares 295 Views 0 Reviews
  • Digital PCR Market Adoption in Agricultural and Plant Genomics

    The Global Digital PCR Market Size is expected to be worth around USD 1,803 Million by 2032 from USD 450 Million in 2022, growing at a CAGR of 15.3% during the forecast period from 2023 to 2032.

    Click here for more information: https://market.us/report/digital-pcr-market/
    Digital PCR Market Adoption in Agricultural and Plant Genomics The Global Digital PCR Market Size is expected to be worth around USD 1,803 Million by 2032 from USD 450 Million in 2022, growing at a CAGR of 15.3% during the forecast period from 2023 to 2032. Click here for more information: https://market.us/report/digital-pcr-market/
    MARKET.US
    Digital PCR Market
    Digital PCR Market is expected to grow at a CAGR of 15.3% over the next ten years and will reach US$ 1868.55 Mn in 2032.
    0 Comments 0 Shares 213 Views 0 Reviews
  • Anti-Obesity Drugs Market Growth and Status Explored in a New Research Report 2035

    Owing to the increased prevalence rate of obesity and need for effective drug products, several researchers and industry stakeholders are increasingly shifting their focus towards the development of anti-obesity drugs

    Anti-obesity drugs consist of various pharmaceutical treatments aimed at helping individuals manage obesity and related health issues.

    The global anti-obesity drugs market size is projected to grow from $12.8 billion in 2024 to $104.9 billion in 2035, representing a CAGR of 21.1%, till 2035.

    These medications provide healthcare professionals with valuable tools to complement lifestyle interventions, such as diet and exercise. They play a critical role in enhancing weight loss outcomes, particularly for patients with significant obesity-related comorbidities. Further, these drugs contribute to improved quality of life and potentially lower healthcare costs by preventing complications associated with obesity.

    Advancements in drug formulation and delivery systems, along with the integration of novel compounds, have led to the emergence of more effective and safer anti-obesity medications. The increasing focus on personalized medicine and pharmacogenomics further enhances the potential for tailored treatments that address individual patient needs. Additionally, the surge in telehealth services and digital therapeutics applications is facilitating better patient engagement and adherence to treatment regimens.

    Type of Molecule

    Biologics

    Small Molecules

    Active Compound Used

    Tirzepatide

    Semaglutide

    Retatrutide

    Survodutide

    Cagrilintide and Semaglutide

    Orforglipron

    Liraglutide

    Other Active Compounds

    Mechanism of Action

    GLP-1 Agonist / GIP Agonist

    GLP-1 Agonist / GCGR Agonist

    GLP-1 Agonist

    GLP-1 Agonist / Amylin Analogue

    GLP-1 / GCGR / GIP Agonist

    Other Mechanisms of Action

    Type of Agonist

    Single-Agonist

    Dual-Agonist

    Tri-Agonist

    It is worth highlighting that there is a significant rise in the interest of stakeholders in anti-obesity drugs segment; this can be validated by the increase in activity of big pharma players within this domain. Further, the growing demand for anti-obesity has compelled the players engaged in this domain to expand their existing capabilities / capacities in order to accommodate the future needs of their clients. With a growing emphasis on obesity as a chronic disease requiring long-term management, the anti-obesity drugs market is poised for robust expansion, offering significant opportunities for stakeholders in the coming years.

    Research Methodology

    Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Agricultural biologicals Market.

    Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/anti-obesity-drugs-market.html

    About Roots Analysis

    Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Browse for more related reports

    https://www.mountainproject.com/user/202070205/jhanvi-kukreja

    https://www.upcarta.com/posts/243344

    https://app.simplenote.com/p/DYrgGl

    https://www.facetwig.com/read-blog/189998

    https://community.shorthand.com/Feature-Wishlist/post/cold-chain-market-for-pharmaceuticals-share-global-industry-size-aWX6ZKaC7fXFl7n

    https://www.musicaltouch.sg/profile/jhanvikukreja41638019/profile

    https://www.ashevilleglamping.com/profile/jhanvikukreja41693542/profile

    https://gitlab.chabokan.net/jhanvi0001/roots/-/issues/1

    https://www.mountainproject.com/user/202070205/jhanvi-kukreja

    https://oye.participer.lyon.fr/profiles/jhanvi001654/activity

    http://inuyasha-fanfiction.com/viewuser.php?uid=61766

    https://8x15m.mssg.me/

    https://jali.pro/jhanvi933

    https://www.upcarta.com/posts/243344

    We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

    The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

    Contact:

    Roots Analysis

    [email protected]
    Anti-Obesity Drugs Market Growth and Status Explored in a New Research Report 2035 Owing to the increased prevalence rate of obesity and need for effective drug products, several researchers and industry stakeholders are increasingly shifting their focus towards the development of anti-obesity drugs Anti-obesity drugs consist of various pharmaceutical treatments aimed at helping individuals manage obesity and related health issues. The global anti-obesity drugs market size is projected to grow from $12.8 billion in 2024 to $104.9 billion in 2035, representing a CAGR of 21.1%, till 2035. These medications provide healthcare professionals with valuable tools to complement lifestyle interventions, such as diet and exercise. They play a critical role in enhancing weight loss outcomes, particularly for patients with significant obesity-related comorbidities. Further, these drugs contribute to improved quality of life and potentially lower healthcare costs by preventing complications associated with obesity. Advancements in drug formulation and delivery systems, along with the integration of novel compounds, have led to the emergence of more effective and safer anti-obesity medications. The increasing focus on personalized medicine and pharmacogenomics further enhances the potential for tailored treatments that address individual patient needs. Additionally, the surge in telehealth services and digital therapeutics applications is facilitating better patient engagement and adherence to treatment regimens. Type of Molecule Biologics Small Molecules Active Compound Used Tirzepatide Semaglutide Retatrutide Survodutide Cagrilintide and Semaglutide Orforglipron Liraglutide Other Active Compounds Mechanism of Action GLP-1 Agonist / GIP Agonist GLP-1 Agonist / GCGR Agonist GLP-1 Agonist GLP-1 Agonist / Amylin Analogue GLP-1 / GCGR / GIP Agonist Other Mechanisms of Action Type of Agonist Single-Agonist Dual-Agonist Tri-Agonist It is worth highlighting that there is a significant rise in the interest of stakeholders in anti-obesity drugs segment; this can be validated by the increase in activity of big pharma players within this domain. Further, the growing demand for anti-obesity has compelled the players engaged in this domain to expand their existing capabilities / capacities in order to accommodate the future needs of their clients. With a growing emphasis on obesity as a chronic disease requiring long-term management, the anti-obesity drugs market is poised for robust expansion, offering significant opportunities for stakeholders in the coming years. Research Methodology Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Agricultural biologicals Market. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/anti-obesity-drugs-market.html About Roots Analysis Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Browse for more related reports https://www.mountainproject.com/user/202070205/jhanvi-kukreja https://www.upcarta.com/posts/243344 https://app.simplenote.com/p/DYrgGl https://www.facetwig.com/read-blog/189998 https://community.shorthand.com/Feature-Wishlist/post/cold-chain-market-for-pharmaceuticals-share-global-industry-size-aWX6ZKaC7fXFl7n https://www.musicaltouch.sg/profile/jhanvikukreja41638019/profile https://www.ashevilleglamping.com/profile/jhanvikukreja41693542/profile https://gitlab.chabokan.net/jhanvi0001/roots/-/issues/1 https://www.mountainproject.com/user/202070205/jhanvi-kukreja https://oye.participer.lyon.fr/profiles/jhanvi001654/activity http://inuyasha-fanfiction.com/viewuser.php?uid=61766 https://8x15m.mssg.me/ https://jali.pro/jhanvi933 https://www.upcarta.com/posts/243344 We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis [email protected]
    WWW.ROOTSANALYSIS.COM
    Anti-Obesity Drugs Market Size, Share, Growth Report [2035]
    Anti-obesity drugs market size is expected to grow from USD 12.8 billion in 2024 to USD 19.6 billion in 2025 and USD 104.9 billion by 2035, at a CAGR of 18.3%
    0 Comments 0 Shares 3K Views 0 Reviews
  • a detailed and up-to-date scientific article on Nutrition and Diet .

    The Science of Nutrition and Diet: Foundations for Health and Longevity

    Abstract
    Nutrition is a cornerstone of human health, impacting everything from disease prevention to mental well-being. In recent decades, research has advanced our understanding of how specific dietary patterns, macronutrient balance, micronutrient adequacy, and emerging fields like nutrigenomics contribute to optimal health. This article explores the latest findings in nutritional science, outlines evidence-based dietary strategies, and highlights the future of personalized nutrition.


    ---

    Introduction

    Nutrition refers to the intake and utilization of food substances by the body for growth, maintenance, and energy. A well-structured diet provides essential nutrients—carbohydrates, proteins, fats, vitamins, minerals, and water—needed for various physiological functions. However, modern dietary patterns have shifted dramatically, often contributing to the rise of non-communicable diseases (NCDs) such as obesity, type 2 diabetes, and cardiovascular disease.

    Macronutrients: Quality Over Quantity

    1. Carbohydrates

    Carbohydrates remain a primary energy source. However, their quality is critical:

    High glycemic index (GI) foods (e.g., white bread, sugary drinks) are linked to insulin resistance.

    Whole grains and fiber-rich carbohydrates (e.g., oats, quinoa) improve metabolic health.


    2. Proteins

    Adequate protein intake is essential for muscle repair, immune function, and enzyme production:

    Animal-based proteins (meat, eggs, dairy) offer complete amino acid profiles.

    Plant-based proteins (legumes, nuts, soy) are associated with lower chronic disease risk.


    3. Fats

    Fat types are more important than total fat:

    Unsaturated fats (from olive oil, fish, nuts) support heart health.

    Saturated and trans fats are linked to increased LDL cholesterol and cardiovascular disease risk.

    Micronutrients: The Hidden Deficiency

    Micronutrient deficiencies—often called "hidden hunger"—can exist even in calorie-sufficient diets. Common global concerns include:

    Iron (linked to anemia)

    Vitamin D (crucial for immunity and bone health)

    Iodine (important for thyroid function)

    Zinc (immune and cellular function)


    Bioavailability, or the body’s ability to absorb these nutrients, is often influenced by diet composition and individual health.


    Dietary Patterns and Health Outcomes

    Rather than focusing solely on individual nutrients, dietary patterns are now emphasized.

    1. Mediterranean Diet

    Rich in fruits, vegetables, whole grains, olive oil, and fish. It is strongly associated with:

    Reduced risk of heart disease and stroke

    Improved cognitive function


    2. DASH Diet (Dietary Approaches to Stop Hypertension)

    Designed to lower blood pressure, it emphasizes:

    Low sodium

    High intake of potassium, magnesium, calcium


    3. Plant-Based Diets

    Linked to:

    Lower body weight

    Reduced type 2 diabetes risk

    Environmental sustainability


    The Role of the Gut Microbiome

    Emerging evidence shows that the gut microbiota—trillions of microorganisms in the digestive tract—plays a crucial role in digestion, immunity, and even mood regulation.

    Diets rich in prebiotics (e.g., fiber) and probiotics (e.g., yogurt, kefir) enhance microbial diversity.

    Dysbiosis (imbalanced microbiome) is associated with inflammation, obesity, and autoimmune diseases.

    Nutrigenomics: Personalized Nutrition

    Nutrigenomics explores how genes interact with dietary components:

    Certain gene variants may influence how individuals metabolize fats, absorb vitamins, or respond to caffeine.

    Personalized diets based on genetic testing are becoming more accessible but require further validation for widespread application.


    Modern Challenges and Considerations

    1. Ultra-Processed Foods (UPFs)

    High in additives, sugar, and unhealthy fats, UPFs are linked to:

    Obesity

    Mood disorders

    Metabolic syndrome


    2. Food Insecurity and Malnutrition

    Despite global food abundance, malnutrition (both under- and over-nutrition) persists due to socioeconomic disparities, poor food distribution, and misinformation.


    Future Directions

    AI and wearable tech are transforming how individuals track and adjust their diets.

    Sustainable nutrition aims to create diets that benefit both human health and planetary well-being.

    Synthetic biology and lab-grown foods could address global food security in the coming decades.



    Conclusion

    The science of nutrition is evolving from one-size-fits-all recommendations to a more integrated, personalized approach. A diet that prioritizes whole, nutrient-dense foods, supports a healthy microbiome, and accounts for individual genetic and lifestyle factors is key to enhancing health and longevity .

    #diet #detox #lifestyle
    #healthy #balance #food
    #healthyfood #nutrition
    #natural #life
    a detailed and up-to-date scientific article on Nutrition and Diet . The Science of Nutrition and Diet: Foundations for Health and Longevity Abstract Nutrition is a cornerstone of human health, impacting everything from disease prevention to mental well-being. In recent decades, research has advanced our understanding of how specific dietary patterns, macronutrient balance, micronutrient adequacy, and emerging fields like nutrigenomics contribute to optimal health. This article explores the latest findings in nutritional science, outlines evidence-based dietary strategies, and highlights the future of personalized nutrition. --- Introduction Nutrition refers to the intake and utilization of food substances by the body for growth, maintenance, and energy. A well-structured diet provides essential nutrients—carbohydrates, proteins, fats, vitamins, minerals, and water—needed for various physiological functions. However, modern dietary patterns have shifted dramatically, often contributing to the rise of non-communicable diseases (NCDs) such as obesity, type 2 diabetes, and cardiovascular disease. Macronutrients: Quality Over Quantity 1. Carbohydrates Carbohydrates remain a primary energy source. However, their quality is critical: High glycemic index (GI) foods (e.g., white bread, sugary drinks) are linked to insulin resistance. Whole grains and fiber-rich carbohydrates (e.g., oats, quinoa) improve metabolic health. 2. Proteins Adequate protein intake is essential for muscle repair, immune function, and enzyme production: Animal-based proteins (meat, eggs, dairy) offer complete amino acid profiles. Plant-based proteins (legumes, nuts, soy) are associated with lower chronic disease risk. 3. Fats Fat types are more important than total fat: Unsaturated fats (from olive oil, fish, nuts) support heart health. Saturated and trans fats are linked to increased LDL cholesterol and cardiovascular disease risk. Micronutrients: The Hidden Deficiency Micronutrient deficiencies—often called "hidden hunger"—can exist even in calorie-sufficient diets. Common global concerns include: Iron (linked to anemia) Vitamin D (crucial for immunity and bone health) Iodine (important for thyroid function) Zinc (immune and cellular function) Bioavailability, or the body’s ability to absorb these nutrients, is often influenced by diet composition and individual health. Dietary Patterns and Health Outcomes Rather than focusing solely on individual nutrients, dietary patterns are now emphasized. 1. Mediterranean Diet Rich in fruits, vegetables, whole grains, olive oil, and fish. It is strongly associated with: Reduced risk of heart disease and stroke Improved cognitive function 2. DASH Diet (Dietary Approaches to Stop Hypertension) Designed to lower blood pressure, it emphasizes: Low sodium High intake of potassium, magnesium, calcium 3. Plant-Based Diets Linked to: Lower body weight Reduced type 2 diabetes risk Environmental sustainability The Role of the Gut Microbiome Emerging evidence shows that the gut microbiota—trillions of microorganisms in the digestive tract—plays a crucial role in digestion, immunity, and even mood regulation. Diets rich in prebiotics (e.g., fiber) and probiotics (e.g., yogurt, kefir) enhance microbial diversity. Dysbiosis (imbalanced microbiome) is associated with inflammation, obesity, and autoimmune diseases. Nutrigenomics: Personalized Nutrition Nutrigenomics explores how genes interact with dietary components: Certain gene variants may influence how individuals metabolize fats, absorb vitamins, or respond to caffeine. Personalized diets based on genetic testing are becoming more accessible but require further validation for widespread application. Modern Challenges and Considerations 1. Ultra-Processed Foods (UPFs) High in additives, sugar, and unhealthy fats, UPFs are linked to: Obesity Mood disorders Metabolic syndrome 2. Food Insecurity and Malnutrition Despite global food abundance, malnutrition (both under- and over-nutrition) persists due to socioeconomic disparities, poor food distribution, and misinformation. Future Directions AI and wearable tech are transforming how individuals track and adjust their diets. Sustainable nutrition aims to create diets that benefit both human health and planetary well-being. Synthetic biology and lab-grown foods could address global food security in the coming decades. Conclusion The science of nutrition is evolving from one-size-fits-all recommendations to a more integrated, personalized approach. A diet that prioritizes whole, nutrient-dense foods, supports a healthy microbiome, and accounts for individual genetic and lifestyle factors is key to enhancing health and longevity . #diet #detox #lifestyle #healthy #balance #food #healthyfood #nutrition #natural #life
    0 Comments 0 Shares 1K Views 0 Reviews
More Results